baber/WOPTO huggingface dataset:
Patent CA-3157208-A1 (CA)
Inventor: PERLADE ASTRID
IPC: C22C38/02
Filed: 2020-12-17
Abstract: L'invention concerne une feuille d'acier laminée à chaud et traitée thermiquement présentant une composition comprenant, en pourcentage en poids : C de 0,12 à 0,25 %, Mn de 3,0 à 8,0 %, Si de 0,70 à 1,50 %, Al de 0,3 à 1,2 %, B de 0,0002 à 0,004 %, S = 0,010 %, P = 0,020 %, N < 0,008 %, le reste de la composition étant du fer et des impuretés inévitables résultant de la fusion, et présentant une microstructure constituée de, en fraction de surface : entre 5 % et 45 % de ferrite, entre 25 % et 85 % de martensite fractionnée, ladite martensite fractionnée présentant une densité de carbures inférieure à 2x106 /mm2, entre 10 % et 30 % d'austénite résiduelle, moins de 8 % de martensite fraîche, une partie de ladite martensite fraîche étant combinée avec de l'austénite résiduelle sous la forme d'îlots martensite-austénite dans une fraction de surface totale inférieure à 10 %, et un indice d'aplatissement inférieur à 5.
Patent CA-3159918-A1 (CA)
Inventor: RAUCH SASCHA
IPC: B32B9/00
Filed: 2020-11-04
Abstract: L'invention concerne un tapis émetteur de lumière ou un panneau de garniture d'émission de lumière qui utilise une feuille de polymère translucide qui a une couche protectrice et une pluralité de cavités conçues pour accepter une pluralité de diodes électroluminescentes (DEL) agencées pour générer de la lumière, les DEL étant conçues pour être alignées et projeter la lumière dans les cavités de feuille de polymère.
Patent CA-3161894-A1 (CA)
Title: Optimizing patient placement and sequencing in a dynamic medical system using a complex heuristic with embedded machine learning
Inventor: DAY ANDREW
IPC: G06Q10/06
Filed: 2020-12-14
Abstract: Techniques for optimizing patient placement and sequencing in dynamic medical environment. In various embodiments, a method includes receiving current state information regarding a current state of a medical facility system in real-time, including operating conditions data regarding current operating conditions of the medical facility system and patient case data regarding active patient cases and pending patient cases of the medical facility system. It further includes forecasting future state information for the medical facility system based on the current state information using a machine learning framework, including forecasted timeline information regarding future timing of workflow events of the active patient cases and pending patient cases. It further includes employing a heuristic-based optimization mechanism to determine optimal reactive solutions regarding patient sequencing, patient placement and resource allocation based on the current state information, the future state information, rules of the medical care facility system, and one or more optimization criteria.
Patent CA-3162388-A1 (CA)
Inventor: CASTRO ALFREDO C
IPC: C07D417/14
Filed: 2020-12-18
Abstract: La présente invention concerne des dérivés de 4-phényl-N-(phényl)thiazol-2-amine et de 4-(pyridin-3-yl)-N-(phényl)thiazol-2-amine ainsi que les dérivés thiadiazole, thiophène, oxazole, oxadiazole, imidazole et triazole correspondants et des composés associés utilisés comme agonistes du récepteur d'hydrocarbure aryle (AHR) pour le traitement de troubles liés à l'angiogenèse, tels que, par exemple, la rétinopathie, le psoriasis, la polyarthrite rhumatoïde, l'obésité et le cancer, ou de troubles inflammatoires.
Patent CA-3163958-A1 (CA)
Inventor: PUROLA VELI MATTI
IPC: C10G9/36
Filed: 2020-12-09
Abstract: A process is provided for improving energy efficiency and reducing greenhouse gas emissions in a hydrocarbon processing and/or production facility, through rearrangement of thermal energy distribution within said facility, said facility comprising a cracker unit (100A) with at least one apparatus (202) for cracking a hydrocarbon containing feed (1), in presence of a dilution medium, wherein a cracked gaseous effluent exiting the apparatus is instantly cooled in a transfer line exchanger (TLE) (301) while generating high-pressure steam, in which process any one of the: heating and/or vaporizing the hydrocarbon containing feed and/or the dilution medium, heating and/or vaporizing boiler feed water, and superheating high pressure steam generated in the TLE unit, is conducted in a heat recovery unit (HRU) (302) arranged downstream the TLE, and which process comprises supplying electrical power into the hydrocarbon processing and/or production facility.
Patent CA-3164115-A1 (CA)
Inventor: SNEAD LANCE
IPC: H01M10/653
Filed: 2021-01-21
Abstract: L'invention concerne des structures composites dont la matrice composite est une phase contenant de l'oxyde de magnésium entièrement dense (supérieure à 95 %) et dont la phase entraînée, grâce à sa température de décomposition ou à sa réactivité chimique, ne pourrait autrement pas être fabriquée. En particulier, l'invention concerne une méthodologie selon laquelle une gamme de structures composites est formée par application d'une technique de fabrication avancée et d'un mélange de poudres de céramique dont le frittage est amélioré par de petites quantités d'un auxiliaire de frittage à l'halogénure métallique. Cette méthodologie et ce procédé réduisent significativement la température de traitement de céramiques réfractaires telles que l'oxyde de magnésium permettant une formation de corps céramiques incorporant des phases telles que des hydrures métalliques, des phases céramiques fragiles et des espèces hautement réactives telles que des beryllures. Dans tous les cas, le produit final est sensiblement exempt, voire dépourvu, de l'auxiliaire de frittage à l'halogénure métallique, ce qui permet d'obtenir une matrice céramique à phase pure composée de la phase hôte et de la phase entraînée.
Patent CA-3165675-A1 (CA)
Inventor: NORMAN TIMOTHY JOHN
IPC: C07D221/06
Filed: 2020-12-22
Abstract: The present invention relates to tetrahydrobenzo-isoquinoline sulfonamide derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use in treating disorders caused by IgE (such as allergic responses, non-allergic mast cell responses or certain autoimmune responses), and in particular disorders caused by the interaction of IgE with the FceRI receptor.
Patent CA-3167781-A1 (CA)
Inventor: FATTAL DAVID A
IPC: G02F1/1335
Filed: 2021-01-22
Abstract: A reflective microprism scattering element based backlight, a multiview display, and a method backlight operation include reflective microprism reflective scattering elements configured to provide emitted light having a predetermined light exclusion zone. The reflective microprism scattering element based backlight includes a light guide configured to guide light and a plurality of the reflective microprism scattering elements having sloped reflective sidewalls configured to reflectively scatter out the guided light as the emitted light. The sloped reflective sidewalls of the reflective microprism scattering elements are configured to provide the predetermined light exclusion zone of the emitted light. The multiview display includes the reflective microprism scattering elements arranged as an array of reflective microprism multibeam elements. The multiview display also includes an array of light valves to modulate the directional light beams to provide the multiview image, except within the predetermined light exclusion zone.
Patent CA-3167842-A1 (CA)
Inventor: RONTGEN MONIKA
IPC: A23L13/00
Filed: 2020-10-14
Abstract: The present invention relates to a method for producing a composition which comprises animal protein, comprising (a) isolating precursor cells from perinatal tissue of a mammal; (b) incubating the precursor cells under conditions which lead to a myogenic differentiation of the precursor cells; and (c) harvesting the cells. The present invention also relates to a method for producing precursor cells from perinatal tissue, to animal protein produced according to the invention, and precursor cells produced according to the invention. The present invention further relates to the use of a culture medium which has a reduced content of methionine in comparison to standard medium, to the differentiation of precursor cells, and to a method for the in vitro production of a meat-like composition.
Patent CA-3168290-A1 (CA)
Title: Inter-agency communication system for promoting situational awareness
Inventor: PIETT WILLIAM TODD
IPC: G06Q10/063
Filed: 2022-07-20
Abstract: An inter-agency communication system configured to translate unnonnalized data from emergency-response agencies into normalized data, to identify an actionable incident from the normalized data and to output a workflow corresponding to the actionable incident and/or to cause selected information concerning the actionable incident to be placed into a situational-awareness container to be made available to the emergency-response agencies.
Patent CA-3168889-A1 (CA)
Title: Heat sealing member
Inventor: ZAMORA RAFAEL
IPC: B65D51/00
Filed: 2021-02-12
Abstract: Various enhancements of heat seals are provided herein with sealant layers that provide for decreased chance of oversealing the heat seal to a container. Such enhancements include the use of various types of resins in combination to provide for desirable heating and sealing characteristics. Further, the heat seals may be especially suitable for use with polyester containers, such as those containing polyethylene terephthalate.
Patent CA-3172638-A1 (CA)
Title: Solid dispersions of rifaximin for the treatment of overt hepatic encephalopathy
Inventor: HEIMANSON ZEEV
IPC: A61P1/16
Filed: 2021-03-24
Abstract: Provided herein are solid dispersions comprising rifaximin and methods of using the same for the treatment of Overt Hepatic Encephalopathy and complications associated with cirrhosis.
Patent CA-3175210-A1 (CA)
Title: Synthese d'un inhibiteur de monoacylglycerol lipase
Inventor: GRICE CHERYL A
IPC: C07D295/205
Filed: 2021-04-19
Abstract: La présente invention concerne la production d'un inhibiteur de MAGL 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2- (pyrrolidin-1-yl)-4-(trifluorométhyl)benzyl)pipérazine-1-carboxylate, y compris des sels de celui-ci.
Patent CA-3175624-A1 (CA)
Title: Packaging for a medical device
Inventor: KENDRICK ANDREW
IPC: A61M25/00
Filed: 2021-04-23
Abstract: The present invention relates to packaging (10) for housing a medical device (100). The packaging (10) includes first and second sides (12, 14) sealed or otherwise secured around the periphery thereof to define a plurality of edges. An interaction region (24) is provided and defines a first point of contact for a user of the packaging (100). The packaging (10) also includes a tear-away region (28) which may be at least partially separated from the remainder of the packaging to form an open upper end of the packaging (10), in use. The tear-away region (28) includes an interaction point defining a second point of contact for a user of the packaging (10). A sealing arrangement including first and second sealing members (42, 44) provides a user-sealable seal between the first and second sides (12, 14) of the packaging (10).
Patent CA-3176247-A1 (CA)
Inventor: ALCANTARA RICARDO DOS SANTOS ANDRADE DE
IPC: G06Q10/04
Filed: 2022-09-26
Abstract: Systems and methods for optimizing grain supply network can include predicting a volume of a product from each of a plurality of origination sites, predicting a quality of the product from each of the plurality of origination sites, determining one or more constraints for blending the product from the plurality of origination sites to obtain a blended product, and generating a total volume of the product to be used from at least one of the plurality of origination sites for obtaining the blended product such that the blended product is of the desired combined volume and the quality level. The one or more constraints comprises at least a desired combined volume and a quality level. The total volume is determined based on the predicted volume of the product and the predicted quality of the product from each of the plurality of origination sites.
Patent CA-3176864-A1 (CA)
Inventor: HUANG WENHAO
IPC: G06F17/00
Filed: 2019-09-29
Abstract: L'invention concerne un procédé et un appareil de traitement universel destinés à l'interaction de données, appartenant au domaine technique des mégadonnées. Le procédé consiste : à régler, selon une règle prédéfinie d'un service d'interaction de données, un paramètre de données d'initialisation du service d'interaction de données (101) ; dans un scénario d'utilisation actuel, à invoquer le service d'interaction de données en fonction du paramètre de données d'initialisation (102) ; à envoyer une demande de données correspondante en fonction d'un paramètre de données de différence correspondant au scénario d'utilisation actuel (103) ; et à exécuter, en fonction des données renvoyées concernant la demande de données, un traitement de données requis par le scénario d'utilisation actuel (104). Au moyen du procédé et de l'appareil de traitement universel destinés à l'interaction de données, la réutilisation, l'efficacité élevée et la cohérence d'un code peuvent être efficacement améliorées, et la cohérence entre un procédé et un résultat d'interaction de données et des fonctions telles que la commande de version, l'extension de scénario d'utilisation, la surveillance d'environnement et le traitement d'erreur sont également mises en uvre.
Patent CA-3178268-A1 (CA)
Title: Compositions et procedes relatifs aux vesicules extracellulaires derivees des megacaryocytes
Inventor: THON JONATHAN
IPC: C12N5/078
Filed: 2021-05-11
Abstract: L'invention concerne des compositions et des procédés associés à des vésicules extracellulaires dérivées de mégacaryocytes dérivées de cellules souches pluripotentes humaines, les vésicules extracellulaires dérivées de mégacaryocytes pouvant être utilisées pour l'administration de médicaments et le traitement de diverses maladies.
Patent CA-3179592-A1 (CA)
Inventor: TAKEUCHI MAKOTO
IPC: F28F1/32
Filed: 2022-10-12
Abstract: A heat exchanger includes a case, fins, and heat transfer tubes. Combustion exhaust gas passes downward in the case. The fins are disposed at a lower portion of the case and arranged in the first direction. Each of the fins includes a first end and a second end that is an opposite end from the first end in a second direction intersecting the first direction. Each of the fins includes through holes in which the heat transfer tubes are inserted. Each of the fins includes heat receiving portions arranged in the second direction and connecting portion connecting the heat receiving portions. The heat receiving portions include a first heat receiving portion disposed at the first end. The first heat receiving portion includes a first recessed portion recessed from an outer edge of an upper part of the first heat receiving portion. (141 words)
Patent CA-3179780-A1 (CA)
Inventor: AUSTIN TALBIR KAUR
IPC: A61K31/26
Filed: 2021-04-08
Abstract: La présente invention concerne des complexes cristallins de sulforaphane et d'alpha-cyclodextrine ; des compositions pharmaceutiques comprenant les complexes ; leurs procédés de fabrication ; et l'utilisation desdits complexes en tant que médicament.
Patent CA-3180795-A1 (CA)
Inventor: GANAPATHY MANICAVASAGAM
IPC: A61M39/20
Filed: 2021-05-26
Abstract: Système de cathéter pouvant comprendre un adaptateur de cathéter, qui peut comprendre un connecteur sans aiguille, qui peut présenter une extrémité distale, une extrémité proximale et une valve disposée entre l'extrémité distale du connecteur sans aiguille et l'extrémité proximale du connecteur sans aiguille. Le système de cathéter peut comprendre un ensemble évent, qui peut comprendre un composant proximal et un composant distal. Le composant proximal peut comprendre un adaptateur de raccord Luer mâle, qui peut comprendre un raccord Luer mâle. Le composant distal peut comprendre une extrémité distale couplée à l'extrémité proximale du connecteur sans aiguille, et une extrémité proximale couplée à l'adaptateur de raccord Luer mâle. En réponse au mouvement du composant proximal d'une position proximale à une position distale relativement au composant distal, le raccord Luer mâle de l'adaptateur de raccord Luer mâle peut ouvrir la valve pour évacuer l'air à l'intérieur du système de cathéter.
Patent CA-3181984-A1 (CA)
Title: Systems and methods for producing a bundle of filaments and/or a yarn
Inventor: CASCIO ANTHONY
IPC: B65H51/22
Filed: 2021-06-16
Abstract: Systems for producing M yarns, wherein M ? 1, include N extruders, M spin stations, and a processor, wherein N > 1. Each extruder includes a thermoplastic polymer having a color, hue, and/or dyability characteristic, which are different from each other. Each spin station produces one yarn comprising at least one bundle of filaments. Each spin station comprises at least one spinneret through which filaments are spun from at least two molten thermoplastic polymer streams received by the respective spin station and N spin pumps upstream of the spinneret for the respective spin station. Each spin pump is paired with one of the N extruders. The processor is in electrical communication with the N*M spin pumps and is configured to adjust the volumetric flow rate of the polymers pumped from each spin pump to achieve a ratio of the polymers to be included in each M yarn.
Patent CA-3184534-A1 (CA)
Title: Container and manufacture thereof
Inventor: CLARKE PETER REGINALD
IPC: B65D81/26
Filed: 2021-07-16
Abstract: A container (202) comprising an annular sidewall (204) which comprises upper and lower annular peripheral edges and a lattice structure (213) of elongate ribs (214) interconnecting the upper and lower annular peripheral edges, wherein the lattice structure is an open framework defining a plurality of sidewall openings (225), and a base (210) which comprises an annular peripheral edge which is integral with the lower annular peripheral edge of the sidewall, the annular peripheral edge of the base surrounding a base wall structure which is integral therewith, the base wall structure comprising at least one injection moulding sprue at a central region of the base wall structure, wherein the at least one injection moulding sprue is connected to the upper annular peripheral edge of the annular sidewall by the base wall structure, the annular peripheral edge of the base, the lower annular peripheral edge of the sidewall and the lattice structure of the sidewall, wherein the sidewall and the base are composed of a thermoplastic polymer and define a central concavity for packaging a product, and wherein the container further comprises a flexible sheet (250) which is bonded to the lattice structure to cover the sidewall openings and form a sealed sidewall surface of the container.
Patent CA-3187514-A1 (CA)
Title: Inhibiteurs de raf bicycliques fusionnes et leurs procedes d'utilisation
Inventor: BELFIELD ANDREW
IPC: C07D405/14
Filed: 2021-07-28
Abstract: La présente invention concerne de manière générale une synthèse améliorée d'inhibiteurs de Raf bicycliques fusionnés de formule (I), (I-A), (I-B), (II), ou (III), ou un sel, un tautomère ou un stéréoisomère pharmaceutiquement acceptable de ceux-ci. L'invention concerne également un procédé d'utilisation du composé de formule (I), (I-A), (I-B), (II), ou (III), ou un sel, un tautomère ou un stéréoisomère pharmaceutiquement acceptable de ceux-ci, pour le traitement de maladies telles que le cancer, y compris le cancer colorectal.
Patent CA-3191310-A1 (CA)
Title: Composition having reducibility
Inventor: KITAGAWA TAKANORI
IPC: C12N1/16
Filed: 2021-08-30
Abstract: [Problem] To provide a new technology that enables reducibility to be maintained for a prolonged period of time. [Solution] The present invention uses, in combination: a gel-like object obtained by processing, in a wet-type ball mill, a quartz porphyry containing silicic acid (SiO2), zinc (Zn), copper (Cu), aluminum (Al), iron (Fe), calcium (Ca), magnesium (Mg), potassium (K), strontium (Sr), and phosphorus (P); and a wet-type ball mill processed product of yeast cell walls and/or a hydrothermal reaction product of yeast cell walls.
Patent CA-3193103-A1 (CA)
Title: Procedes de fabrication d'articles en dose unitaire hydrosoluble comprenant des structures fibreuses hydrosolubles
Inventor: SIVIK MARK ROBERT
IPC: B65D5/00
Filed: 2021-10-12
Abstract: L'invention concerne un procédé de fabrication de doses unitaires fibreuses hydrosolubles (30), le procédé comprenant les étapes consistant à : a. distribuer un matériau de toile fibreuse (16), le matériau de toile fibreuse étant délivré sous la forme d'une bande continue (24) de matériau de toile fibreuse ; b. couper le matériau de bande fibreuse dans une direction transversale pour former un motif imbriqué répétitif de doses unitaires fibreuses hydrosolubles transversales et de forme identique (30) ; les doses unitaires hydrosolubles fibreuses étant imbriquées et formant un motif répétitif de doses unitaires fibreuses hydrosolubles transversales et de forme identique.
Patent CA-3194922-A1 (CA)
Inventor: SPENCE PAUL A
IPC: A61F2/24
Filed: 2014-08-14
Abstract: Systems and methods for replacing a native heart valve. An expansible helical anchor is formed as multiple coils adapted to support a heart valve prosthesis. At least one of the coils is normally at a first diameter, and is expandable to a second, larger diameter upon application of radial outward force from within the helical anchor. A gap is defined between adjacent coils sufficient to prevent engagement by at least one of the adjacent coils with the native heart valve. An expansible heart valve prosthesis is provided and is configured to be delivered into the helical anchor and expanded inside the multiple coils into engagement with the at least one coil. This moves at least that coil from the first diameter to the second diameter while securing the helical anchor and the heart valve prosthesis together. The system further includes a seal on the expansible heart valve prosthesis configured to engage the helical anchor and prevent blood leakage past the heart valve prosthesis after implantation of the heart valve prosthesis in the helical anchor. Additional apparatus and methods are disclosed.
Patent CA-3195170-A1 (CA)
Inventor: DRAKAKIS GEORGIOS
IPC: A61P25/00
Filed: 2021-10-15
Abstract: The present invention relates to compositions for use in the treatment, management or amelioration of FMR1 mediated autism and Fragile X Syndrome (FXS), wherein the composition comprises ergot alkaloid, derivatives or mimetics thereof.
Patent CA-3197771-A1 (CA)
Inventor: MA LONG
IPC: H04W12/02
Filed: 2021-11-05
Abstract: Embodiments of the present invention disclose a communication method, a related apparatus, and a system, to reduce occupation of an N32c link resource in an error report sending process. The method in embodiments of the present invention includes: A first security edge protection proxy SEPP device receives a roaming message from an IP exchange IPX operator device, where the roaming message is used to implement a roaming service between the first SEPP device and a second SEPP device. The first SEPP device determines that the roaming message cannot be processed, and sends a feedback message to the IPX device, where the feedback message is used to indicate that the first SEPP device cannot process the roaming message.
Patent CA-3202917-A1 (CA)
Inventor: CHEN XUXING
IPC: C07D487/10
Filed: 2021-12-23
Abstract: The present invention relates to a spirocyclic compound, represented by formula (I), as a KRAS-G12C inhibitor, which can be used in the preparation of a drug for treating KRAS G12C-mediated tumors.